Hamilton, Ont.-based biotech company, Beleave Inc. is beginning work on developing validating technologies targeted at cannabis growers.
Beleave is partnering with Dr. Robert Gossage, a professor in the department of Chemistry and Biology and Dr. Eric Da Silva, an assistant professor of the Department of Physics at Ryerson University to develop portable spectroscopic instruments and non-destructive methodologies that can help authorized cannabis growers to optimize their cultivation process.
Beleave’s subsidiary, First Access Medical Inc. is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
Beleave and principal investigator will also be making use of the Ryerson University Analytical Center to validate their novel instrumentation and methodologies.
A $25,000 Engage grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) has been awarded to help cover some research costs for the six-month project. NSERC invests over $1 billion each year in natural sciences and engineering research in Canada.
NSERC also provides scholarships and hands-on training experience for more than 30,000 post-secondary students and post-doctoral fellows.
U.S. company sold 5 tons of GM salmon in Canada Next Post:
Clementia, Zymeworks lead Canadian biotech momentum